Breaking News Instant updates and real-time market news.

NVS

Novartis

$86.34

3.78 (4.58%)

05:52
06/23/17
06/23
05:52
06/23/17
05:52

Novartis Kisqali receives CHMP opinion as first-line treatment for HR+/HER2-

Novartis announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency has adopted a positive opinion recommending approval of Kisqali in combination with an aromatase inhibitor for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative, or HR+/HER2-, locally advanced or metastatic breast cancer as initial endocrine-based therapy. The CHMP recommendation of combining Kisqali with any aromatase inhibitor means that, if approved, oncologists could prescribe Kisqali with letrozole, anastrozole or exemestane, giving them the discretion to select the therapy they believe is most appropriate for each individual patient.

  • 26

    Jun

  • 12

    Jul

NVS Novartis
$86.34

3.78 (4.58%)

06/08/17
06/08/17
UPGRADE
Target $100

Buy
Kite Pharma upgraded to Buy on Axi-Cel manufacturing edge at BTIG
As previously reported, BTIG analyst Dane Leone upgraded Kite Pharma (KITE) to Buy from Neutral and set a $100 price target on the shares. Data from Novartis (NVS) and Juno (JUNO) have failed to deliver any recognizable differentiation, though Leone gives Kite "a clear win" for the manufacturing of Axi-Cel versus peers, he tells investors. The analyst sees Kite having the cleanest pathway to approval for diffuse large B-cell lymphoma and, given Kite's manufacturing edge, he estimates that Axi-Cel can take about 60% of share within the U.S. DLBCL market.
06/20/17
PIPR
06/20/17
NO CHANGE
Target $557
PIPR
Overweight
Piper says buy Regeneron on today's selloff, ups target to $557
Piper Jaffray analyst Edward Tenthoff recommends using today's weakness in shares of Regeneron Pharmaceuticals (REGN) after Novartis (NVS) reported positive Phase III data on brolucizumab as a buying opportunity. While brolucizumab is a competitive threat to Regeneron's Eylea, Novartis will not file until 2018 due to manufacturing issues, Tenthoff tells investors in a research note. He continues to expect Eylea sales growth of 6.1% to $3.52B this year and 5% to $3.7B in 2018 before brolucizumab hits the market in 2019. Tenthoff raised his price target for Regeneron Pharmaceuticals to $557 from $446 to reflect a higher price-to-earnings multiple and reiterates an Overweight rating on the shares. Positive Dupixent Phase III asthma data this fall would dramatically expand the company's market opportunity, he contends.
06/22/17
RAJA
06/22/17
NO CHANGE
RAJA
Regeneron price target raised to $547 from $475 at Raymond James
Raymond James analyst Christopher Raymond increased his price target on Regeneron (REGN) after meeting with the company's management. After Novartis (NVS) released data on a potential competitor to Regeneron's Eylea, Raymond thinks that Novartis' drug will not be launched for at least two more years. The analyst adds that the launch of Regeneron's Duipxent drug is going well, while the company is confident that upcoming data will show that the drug effectively treats asthma. He remains upbeat on the company's outlook and thinks that the stock can continue to rise. Raymond keeps an Outperform rating on the stock.
06/22/17
LEHM
06/22/17
UPGRADE
LEHM
Equal Weight
Novartis upgraded to Equal Weight from Underweight at Barclays

TODAY'S FREE FLY STORIES

GMRE

Global Medical REIT

$8.98

-0.16 (-1.75%)

22:03
08/21/17
08/21
22:03
08/21/17
22:03
Downgrade
Global Medical REIT rating change  »

Global Medical REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPX

Tempur Sealy

$61.51

0.24 (0.39%)

22:00
08/21/17
08/21
22:00
08/21/17
22:00
Upgrade
Tempur Sealy rating change  »

Tempur Sealy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$83.52

0.11 (0.13%)

, COTY

Coty

$19.55

0.32 (1.66%)

20:25
08/21/17
08/21
20:25
08/21/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$83.52

0.11 (0.13%)

COTY

Coty

$19.55

0.32 (1.66%)

TOL

Toll Brothers

$38.26

0.11 (0.29%)

DSW

DSW

$15.69

-0.15 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 20

    Sep

ENR

Energizer

$41.24

-0.09 (-0.22%)

18:58
08/21/17
08/21
18:58
08/21/17
18:58
Hot Stocks
Energizer CEO acquires 12,112 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOMB

Home Bancshares

$23.51

0.11 (0.47%)

, SGBK

Stonegate Bank

$46.70

0.34 (0.73%)

18:41
08/21/17
08/21
18:41
08/21/17
18:41
Hot Stocks
Home Bancshares receives regulatory approvals for merger with Stonegate Bank »

Home BancShares (HOMB)…

HOMB

Home Bancshares

$23.51

0.11 (0.47%)

SGBK

Stonegate Bank

$46.70

0.34 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

ADP

ADP

$102.89

-1.52 (-1.46%)

18:32
08/21/17
08/21
18:32
08/21/17
18:32
Periodicals
ADP CEO: Ackman refused to meet because he needed 'leverage,' CNBC says »

After ADP said its board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

TWX

Time Warner

$102.11

0.92 (0.91%)

, SNAP

Snap

$13.58

-0.43 (-3.07%)

18:18
08/21/17
08/21
18:18
08/21/17
18:18
Periodicals
CNN begins streaming daily news show on Snapchat, Reuters reports »

CNN, which is owned by…

TWX

Time Warner

$102.11

0.92 (0.91%)

SNAP

Snap

$13.58

-0.43 (-3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 24

    Aug

  • 13

    Sep

KKR

KKR

18:11
08/21/17
08/21
18:11
08/21/17
18:11
Hot Stocks
Breaking Hot Stocks news story on KKR »

ValueAct raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZUN

Baozun

$34.60

0.62 (1.82%)

18:05
08/21/17
08/21
18:05
08/21/17
18:05
Hot Stocks
Baozun reports Q2 Total Gross Merchandise Volume RMB3.604B »

An increase of 63.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

BZUN

Baozun

$34.60

0.62 (1.82%)

18:03
08/21/17
08/21
18:03
08/21/17
18:03
Earnings
Baozun sees Q3 revenue RMB870M-RMB910M »

The company will begin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

BZUN

Baozun

$34.60

0.62 (1.82%)

18:02
08/21/17
08/21
18:02
08/21/17
18:02
Earnings
Breaking Earnings news story on Baozun »

Baozun reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

BZUN

Baozun

$34.60

0.62 (1.82%)

18:01
08/21/17
08/21
18:01
08/21/17
18:01
Earnings
Baozun reports Q2 EPS 8c, consensus 10c »

Reports Q2 revenue $131M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

KKR

KKR

18:00
08/21/17
08/21
18:00
08/21/17
18:00
Periodicals
KKR near 'clinching' $3B commitment from NYC pension system, Bloomberg says »

KKR is getting close to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESV

Ensco

$4.19

-0.09 (-2.10%)

, NBL

Noble Energy

$23.54

-0.11 (-0.47%)

17:56
08/21/17
08/21
17:56
08/21/17
17:56
Hot Stocks
Ensco awarded contract by Noble Energy »

Ensco (ESV) announced…

ESV

Ensco

$4.19

-0.09 (-2.10%)

NBL

Noble Energy

$23.54

-0.11 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 05

    Oct

GDOT

Green Dot

$46.58

0.31 (0.67%)

17:51
08/21/17
08/21
17:51
08/21/17
17:51
Hot Stocks
Breaking Hot Stocks news story on Green Dot »

Harvest Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RT

Ruby Tuesday

$1.84

-0.06 (-3.16%)

, RIG

Transocean

$7.32

-0.16 (-2.14%)

17:46
08/21/17
08/21
17:46
08/21/17
17:46
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Ruby…

RT

Ruby Tuesday

$1.84

-0.06 (-3.16%)

RIG

Transocean

$7.32

-0.16 (-2.14%)

NDSN

Nordson

$125.12

0.99 (0.80%)

FN

Fabrinet

$39.82

-0.26 (-0.65%)

TEDU

Tarena

$18.61

0.59 (3.27%)

ZAYO

Zayo Group

$32.97

-0.08 (-0.24%)

PINC

Premier

$32.78

-0.16 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 29

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 06

    Dec

RIG

Transocean

$7.32

-0.16 (-2.14%)

17:41
08/21/17
08/21
17:41
08/21/17
17:41
Hot Stocks
Transocean director acquires 2,000 registered shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

RDN

Radian Group

$16.46

-0.26 (-1.56%)

17:38
08/21/17
08/21
17:38
08/21/17
17:38
Hot Stocks
Radian Group CEO Thornberry buys 15,000 shares »

Radian Group CEO Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RT

Ruby Tuesday

$1.84

-0.06 (-3.16%)

17:38
08/21/17
08/21
17:38
08/21/17
17:38
Earnings
Ruby Tuesday reports Q4 adjusted EPS 6c vs 10c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 06

    Dec

SRNE

Sorrento Therapeutics

$1.70

-0.05 (-2.86%)

17:29
08/21/17
08/21
17:29
08/21/17
17:29
Hot Stocks
Sorrento closes transactions contemplated by contribution pact with Celularity »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

GPN

Global Payments

$94.57

0.81 (0.86%)

17:24
08/21/17
08/21
17:24
08/21/17
17:24
Hot Stocks
Global Payments Chairman William Jacobs sells 8,428 shares of company stock »

Global Payments Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$267.70

0.09 (0.03%)

17:19
08/21/17
08/21
17:19
08/21/17
17:19
Hot Stocks
Northrop Grumman awarded $328.6M government contract »

Northrop Grumman Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

BA

Boeing

$235.68

-0.09 (-0.04%)

17:18
08/21/17
08/21
17:18
08/21/17
17:18
Hot Stocks
Boeing awarded $349.2M government contract »

The Boeing Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$301.88

2.68 (0.90%)

17:17
08/21/17
08/21
17:17
08/21/17
17:17
Hot Stocks
Lockheed Martin awarded $427M government contract »

Lockheed Martin Corp.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

PBFX

PBF Logistics

$20.80

-0.05 (-0.24%)

17:11
08/21/17
08/21
17:11
08/21/17
17:11
Hot Stocks
Breaking Hot Stocks news story on PBF Logistics »

Carlos Slim reports 5.1%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.